Your browser doesn't support javascript.
loading
Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.
Kato, Ryo; Yamasaki, Makoto; Urakawa, Shinya; Nishida, Kentaro; Makino, Tomoki; Morimoto-Okazawa, Akiko; Kawashima, Atsunari; Iwahori, Kota; Suzuki, Susumu; Ueda, Ryuzo; Mori, Masaki; Satoh, Taroh; Doki, Yuichiro; Wada, Hisashi.
Afiliação
  • Kato R; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Yamasaki M; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
  • Urakawa S; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
  • Nishida K; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Makino T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
  • Morimoto-Okazawa A; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Kawashima A; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
  • Iwahori K; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
  • Suzuki S; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Ueda R; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Mori M; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan.
  • Satoh T; Department of Tumor Immunology, Aichi Medical University of Medicine, Nagakute, Aichi, Japan.
  • Doki Y; Department of Tumor Immunology, Aichi Medical University of Medicine, Nagakute, Aichi, Japan.
  • Wada H; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
Cancer Immunol Immunother ; 67(11): 1673-1683, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30128737
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Leucócitos Mononucleares / Carcinoma de Células Escamosas / Linfócitos T / Receptor Celular 2 do Vírus da Hepatite A / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Leucócitos Mononucleares / Carcinoma de Células Escamosas / Linfócitos T / Receptor Celular 2 do Vírus da Hepatite A / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article